Go Back

AliveCor Expands Mobile ECG Device Offering to United Kingdom & Ireland

SAN FRANCISCO, Calif. June 24, 2013

Now available for iPhone 5 to medical professionals, patients, and health-conscious individuals

AliveCor, Inc. announced today that its Heart Monitor for iPhone 4, 4S and 5 is now available for purchase in the United Kingdom and Ireland. To support the launch, the AliveCor Heart Monitor will be on display at the European Heart Rhythm Association (EHRA) Europace 2013 meeting (booth number H3-B220) in Athens, Greece, beginning June 23. It is the first CE-marked mobile device–based ECG monitor that is used to record, display, store and transfer single-channel electrocardiogram (ECG) rhythms. It is available to medical professionals, patients, and health-conscious individuals at Amazon.co.uk.

“The simplicity and convenience of the AliveCor device is extraordinary,” said John Camm, M.D., Professor of Clinical Cardiology, SGUL. “The Heart Monitor increases the accessibility of ECGs, giving everyone the ability to record anytime, anywhere.” Camm continued, “You can now capture and review clinical-grade ECG rhythm strips within seconds, without special preparation and without attaching leads.”

AliveCor’s Heart Monitor snaps onto the back of an iPhone to record, display, store, and transfer single-channel electrocardiogram (ECG) rhythms wirelessly with the corresponding, free AliveECG app. Recorded rhythm strips can be of any duration, and are stored in the app and securely in the cloud in PDF format for reviewing, analysis, and printing through AliveCor’s website. Cloud storage is compliant with the UK Data Privacy Act and the Data Protection Directive in the European Union. ECG data is accessible from any web browser.

About AliveCor

AliveCor, Inc., is a privately held company headquartered in San Francisco. The company is dedicated to enabling users to participate in their heart health through the use of the AliveCor® Heart Monitor an innovative mobile health solution.

Most Recent

July 9, 2024

Introduction of AliveCor's revolutionary InstantQT® solution set to streamline ECG evaluation and enhance patient safety across Europe

Read More

June 25, 2024

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

Read More

June 5, 2024

AliveCor’s AI-backed ECG Offerings Featured in New Film Series on Innovative Technologies Presented by the Consumer Technology Association

Read More

Let's transform cardiovascular care together

If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.